Skip to content

Use of Complete Repertory in cases of Female who are not able to have children.

Application of prescribed medicine from rubrics of complete repertory in treating female infertility among age group of 25 to 40 years a prospective single group experimental study - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099517
Enrollment
40
Registered
2025-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Medicine will be dispense in doses as per the need of case and in different potencies such as decimal scale centesimal scale 50millesimal scale etc

Sponsors

Dr Harikrishna Soni
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Prediagnosed and diagnosed cases of infertility will be included according to ICD 11 code GA31.Z Females having uterine disturbances like polyps less then 2cm fibroids less then 5cm cysts less then 5 cm PID etc Females with cases of hypothyroidism and hyperthyroidism taking conventional medication Females having ovulatory disorders like PCOD and PCOS Females with less then or equal to 38 BMI Females who are willing to give consent and eligible for filling the questionnaire form

Exclusion criteria

Exclusion criteria: Female with very low AMH level less then 0.3 ng/dl Female having any STD Females with cancers like endometrial cancer ovarian cancer cervical cancer breast cancer Females with Fallopian tube blockage or damaged Females with congenital uterine abnormality Females undergoing with IVF and IUI or on hormonal therapy Husbands diagnosed with male infertility declining treatment

Design outcomes

Primary

MeasureTime frame
Before Treatment By using USG Abdomen KUB Female Infertility Profile TSH LH FSH PRL AMH CBC Progesterone After Treatment By using UPT Urine Pregnancy Test betaHCGTimepoint: Data will be assessed at the baseline and at the end of treatment upto 12 months and positive change in the UTP strip and increased level of beta HCG will be noticed

Secondary

MeasureTime frame
Ferti QoL questionnaireTimepoint: Ferti QoL questionnaire will be assessed from baseline and at the end of treatment

Countries

India

Contacts

Public ContactDr Harikrishna Soni

Smt A J Savla Homoeopathic medical college and research institute

shckalol@gmail.com9428000782

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026